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Introduction. Neutrophil extracellular traps (NET) consist of a DNA scaﬀold that can be destroyed by Deoxyribonuclease (DNase).
Thus DNases are potential prerequisites for natural counter regulation of NETs formation. In the present study, we determined
the relationship of NETs and DNase after major trauma. Methods. Thirty-nine major trauma patients, 14 with and 25 without
sepsis development were enrolled in this prospective study. Levels of cell-free (cf)-DNA/NETs and DNase were quantiﬁed daily
from admission until day 9 after admission. Results. Levels of cf-DNA/NETs in patients who developed sepsis were signiﬁcantly
increased after trauma. In the early septic phase, DNase values in septic patients were signiﬁcantly increased compared to patients
without sepsis (P<0.05). cf-DNA/NETs values correlated to values of DNase in all trauma patients and patients with uneventful
recovery (P<0.01) but not in septic patients. Recombinant DNase eﬃciently degraded NETs released by stimulated neutrophils
in a concentration-dependent manner in vitro. Conclusions. DNase degrades NETs in a concentration-dependent manner and
therefore could have a potential regulatory eﬀect on NET formation in neutrophils. This may inhibit the antibacterial eﬀects of
NETs or protect the tissue from autodestruction in inadequate NETs release in septic patients.
1.Introduction
Major trauma is associated with the induction of systemic
inﬂammation, development of sepsis, and multiple organ
failure (MOF) [1–3]. Neutrophils are the main types of
eﬀector cells in the innate immune system and are the ﬁrst
line against infection [4–7]. Activated polymorphonuclear
neutrophils play a pivotal role in the systemic inﬂammatory
response syndrome (SIRS) and development of sepsis after
major trauma [8].
In addition to the more traditional mechanism of phago-
cytosis to kill bacteria, it has recently been shown that ac-
tivation of neutrophils can cause the release of neutrophil
extracellular traps (NETs) [9]. NETs are large DNA-associ-
ated molecule complexes carrying nucleic and cytoplasmic
proteins such as histones, elastase, myeloperoxidase (MPO),
pentraxin, lactoferrin, and bactericidal/permeability-in-
creasing protein (BPI) [10, 11]. Each of them has got
strong antimicrobial and/or immunomodulating properties.
Upon activation (by e.g., IL-8, lipopolysaccharide, bacteria,
fungi, or activated platelets) neutrophils start a program that
leads to the formation of NETs [12–14]. The formation of
NETs, recently termed “NETosis”, is an active process and
is distinct from neutrophil apoptosis and necrosis involving
postmortem antimicrobial and proinﬂammatory immune
responses [15]. NETs provide a high local concentration
of antimicrobial components and bind, disarm, and kill
microbes extracellularly as an emergency ﬁrst line defense
mechanism [9]. NET trapping in the tissue may allow the
host to conﬁne an infection and thus reduce the likelihood
for the pathogens to spread into the bloodstream [12].
On the other hand, the high local concentration of NETs-
associated eﬀector molecules may contribute to severe tissue
damage and organ dysfunction and/or failure [16].
Deoxyribonuclease (DNase) I, a Ca2+/Mg2+-dependent
endonuclease, is the major nuclease found in body ﬂuids
such as serum and urine. Its primary function has been
assumedtobethedegradationofdietaryDNAwithintheali-
mentary tract. Moreover, it has been shown that extracellular2 Mediators of Inﬂammation
DNase may account for the chromatin breakdown during
necrosis as a basis of protection against anti-DNA autoim-
munity. DNA is the major structural component of NETs
with granule proteins attached to this DNA backbone [9].
Thus, the DNA scaﬀold of NETs can be destroyed by DNase.
So, aberrant NET formation in combination with lack of
patient’s DNases degrading NETs might contribute to their
prolonged persistence with subsequent tissue damage and/or
autoimmune diseases [17–20]. Furthermore, DNases are
expressed by several bacterial pathogens. Bacterial DNases
act as a virulence determinant by counteracting NETs-
mediated trapping, thereby promoting bacterial spread from
local sites to the bloodstream [17, 18].
Recently it has been shown that NETs kinetics followed
the inﬂammatory course after severe trauma [21]. In the
current study we aimed to determined cfDNA/NETs and
DNase in the serum of critically ill patients during the
early posttraumatic phase. We further provide evidence for
a DNase-mediated dissolution of NETs in vitro.
2.MaterialsandMethods
2.1. Patients. Thirty-nine patients were enrolled in this
prospective study. Study approval was obtained from the
Ethics Review Board of the University of Duesseldorf, Ger-
many. Patients with blunt or penetrating multiple injuries
who were admitted to our Level I Trauma Center with an
Injury Severity Score (ISS) >1 6 ,a n da g e d1 8y e a r sa n do l d e r
were enrolled in this study. Written informed consent was
obtained from all participants or their legal representatives
if the patients lacked consciousness. Exclusion criteria were
death of the patient on day of admission or within the ﬁrst
two days on ICU and withdrawal of patient consent. In
addition, patients with known preexisting immunological
disorders or systemic immunosuppressive medication were
excluded. The severity of injury was assessed by the ISS,
based on the Abbreviated Injury Scale (AIS) [19]. SIRS
and sepsis were deﬁned using the criteria outlined 2005
from the International Sepsis Forum [20]. Patients were
determined as septic if they fulﬁlled criteria for systemic
inﬂammatory response syndrome and had a proven source
of infection. Systemic inﬂammatory response syndrome
was deﬁned by two or more of the following criteria:
temperature >38◦Co r<36◦C; heart rate >90 beats per
minute; respiratory rate >2 0b r e a t h sp e rm i n u t eo ra r t e r i a l
carbon dioxide tension (PaCO2) <32mmHg; white blood
cell count >12.000cells/mm3 or <4.000cells/mm3,o rw i t h
>10% immature (band) forms. In order to evaluate organ
dysfunction/failure,theSequentialOrganFailureAssessment
(SOFA) and Multiple Organ Dysfunction (MOD) score were
determined prospectively every day. In addition clinical
laboratory data, including red and white blood counts, elec-
trolytes, creatinine, blood urea nitrogen, C-reactive protein
(CRP), and liver enzymes were monitored daily. Serum and
EDTA blood were collected on admission to the emergency
room (ER) and on days 1 to 10 after injury. Samples were
centrifuged, immediately frozen, and stored at −80◦C until
further analysis.
2.2. cfDNA/NETs Assay. cfDNA/NETs were quantiﬁed using
the Quant-iT PicoGreen dsDNA assay (Invitrogen GmbH,
Darmstadt, Germany). This assay used to label neutrophil-
derived NETs by targeting the NET containing cf-DNA
directly within serum has been recently developed [22]. The
ﬂuorescence intensity reﬂects the amounts of DNA and was
measured at excitation and emission wavelengths of 485nm
and 530nm, respectively, in a microplate reader (Victor3,
PerkinElmer, Waltham, USA) A standard calibration curve
by means of deﬁned calf thymus DNA (Sigma) amounts
ranging from 0 to 2µg/mL has been used in all analyses.
2.3. Quantiﬁcation of Desoxyribonuklease (DNase) by ELISA.
Desoxyribonuklease (DNase) levels in serum samples were
measured by using ORG 590 DNase Activity Immunometric
EnzymeImmunoassayfortheQuantitativeDeterminationof
DNase Activity (ORGENTEC, Mainz, Germany) according
to the manufacturer’s instructions. Additionally, the concen-
tration of DNase in human sera was quantiﬁed using known
concentrations of the standard provided with rh-DNase1
(0.75 up to 12.5ng/mL).
2.4. Isolation of Human Neutrophils. Human neutrophils
were isolated by discontinuous density-gradient centrifuga-
tion on Percoll (Biochrom, Berlin, Germany) as previously
described [23] .A f t e rh y p o t o n i cl y s i st or e m o v ec o n t a m -
inating erythrocytes, cells were suspended in phosphate-
buﬀered saline (PBS). Purity and viability were routinely
>95% as assessed by forward and side scatter characteristics
of FACScan (BD, Heidelberg, Germany) and trypan blue
exclusion, respectively.
2.5.StimulationofNeutrophilsandNETsRelease. Freshlyiso-
lated neutrophils from healthy volunteers were resuspended
in RPMI 1640 containing 2mM glutamine supplemented
with 100U/mL penicillin, 100µg/mL streptomycin, and 10%
heat inactivated fetal calf serum to a ﬁnal concentration of
2 × 106/mL. Cells were stimulated with 5nM PMA for 3h
at 37◦C in a humidiﬁed atmosphere containing 5% CO2.
ThencfDNA/NETsreleasewasquantiﬁedinthesupernatant.
In addition, supernatants were incubated with 0, 0.02, 0.2,
2.0, and 10µg/mL recombinant DNase (Pulmozyme, Roche,
Swisse) for 3h at 37◦C before cfDNA/NETs quantiﬁcation.
2.6. Immunoﬂuorescence Staining of NETs. For immunoﬂu-
orescence, freshly isolated neutrophils were seeded on poly-
D-lysin-coated coverslips, allowed to adhere, and stimulated
with 50nM PMA for 3h at 37◦C. Cells were further ﬁxed
with 4% PFA and blocked with 5% NGS, 0.3% Triton X-100
in PBS for 30min. To stain NETs, samples were incubated
with a monoclonal mouse antimyeloperoxidase antibody
(1:300) and a secondary FITC-conjugated antibody (1:200;
both Dako, Hamburg, Germany). After staining of DNA
with DAPI, specimens were mounted in Dako ﬂuorescent
mounting medium (Dako). Neutrophil-derived NET for-
mation was visualized by immunoﬂuorescence microscopy
(Axiovert 100, Zeiss, Goettingen, Germany).Mediators of Inﬂammation 3
Table 1: Infection site of sepsis and microbiological pathogens.
Subject Site of infection Pathogen Evidence for sepsis, d
1 Pneumoniae n.d. 8
2 Pneumoniae Escherichia coli 7
3 Pneumoniae Klebsiella pneumoniae 5
4 Pneumoniae Klebsiella pneumoniae 4
5 Pneumoniae Morganella morganii 6
6 Pneumoniae Enterobacter cloacae 4
7 Soft tissue Enterobacter cloacae 8
8 Pneumoniae Morganella morganii 4
Klebsiella oxytoca
9 Pneumoniae Escherichia coli 7
10 Pneumoniae Klebsiella pneumoniae 7
11 Pneumoniae Klebsiella oxytoca 4
12 Pneumoniae Klebsiella pneumoniae 4
13 Pneumoniae Enterococcus faecalis 5
Soft tissue Enterococcus faecalis
14 Pneumoniae Enterobacter cloacae 8
d indicates days after trauma, n.d.: not determined.
2.7. Statistical Analyses. To evaluate diﬀerences between the
study groups, a Kruskal-Wallis test with Dunn’s post hoc
test was performed. Correlation between numerical values
was evaluated by Spearman’s rank correlation coeﬃcient
(r). The Mann-Whitney rank sum test was performed to
compare two groups of values at the same time. Analyses
were performed using GraphPad Prism software (version
5; GraphPad Software, San Diego, CA, USA). Data were
considered to be statistically signiﬁcant at P<0.05.
3. Results
3.1. Demographics. The 39 patients (28 male, 11 female)
enrolled into the study had an ISS of 38.8 ± 2.6( m e a n±
SEM, range 16–75). The mean age was 45.2 ± 3.1y e a r s
(range 19–82 years). From all patients, 14 developed sepsis
(sepsis group) within 5.8 ± 0.4 days (range 4–8 days)
after admission. Infection site of sepsis and microbiological
pathogens for each patient are depicted in Table 1.T h r e e
patients died posttraumatically after 55.2 ± 23.3d a y s( r a n g e
24–147 days). The mean ICU stay was 16.9 ±2.4d a y s( r a n g e
2–74 days). The mean age of the 14 patients (3 female, 11
male)whosubsequentlydevelopedsepsiswas50.3±5.8y ears
(range, 21–82 years). The mean ISS in this patient group
was 45.6 ± 4.9 (range, 16–75). Mean ISS in patients without
sepsis was 35.0 ± 2.7 (range, 16–66). The mean ICU stay in
the sepsis group was 25.5 ± 3.4 days (range 7–50 days) and
in the group without development of a sepsis 12.1 ±2.9d a y s
(range 2–74 days).
3.2. cfDNA/NETs and DNase in Sepsis versus No Sepsis
Group. cfDNA/NETs and DNase values were determined
from admission to the emergency room (ER) until day
9a f t e rt r a u m a .I no r d e rt od e ﬁ n en o r m a lv a l u e s ,b l o o d
samples from 10 healthy volunteers were analyzed for
cfDNA/NETs (median, 116.3; interquartile range (IQR),
102.8 to 131.7ng/mL) and DNAse (median, 3.15; IQR, 2.61
to 3.80ng/mL).
Early after major trauma cf-DNA/NETs values were
signiﬁcantly enhanced in comparison to healthy donors,
decreased within the next days but remain elevated
above normal values of volunteers for the entire period
(Figure 1(a)). However, cfDNA/NETs values of patients who
subsequently developed sepsis increased again at day 5 until
day 9 after trauma (day 5, median, 334.0; interquartile range
(IQR), 209.4 to 482.2ng/mL), whereas the values for those
patients without development of sepsis remained on the
same level (day 5, median, 178.3; interquartile range (IQR),
125.8 to 223.4ng/mL; Figure 1(b)). Signiﬁcant intergroup
diﬀerences were detectable between sepsis and nonsepsis
patients on days 5 to 9 as shown in Figure 1(b).
DNase values were also signiﬁcantly increased on admis-
sion (heathly volunteers: median, 3.145; interquartile range
(IQR), 2.614 to 3.799; all patients at day 0: median,
5.715; interquartile range (IQR), 3.400 to 7.119ng/mL.
Figure 2(a)). Regardless of the development of a sepsis or
not, DNase values decreased within the next days for both
groups and remained on the control level throughout the
entire period.
Patients developed sepsis in the mean 5.8 ± 0.4d a y s
(range 4–8 days) after trauma. In order to investigate the
potential role of cfDNA/NETs and DNase values as markers
for the onset of sepsis, we determined the highest values
of both parameters on the day before (−1), the day of (0),
and the day after (+1) diagnosis of sepsis (Figure 3). These
values were compared to highest values between day 4 and
6 of patients without development of sepsis and healthy
volunteers. During the early phase of a sepsis, cf-DNA/NETs
and DNase in patients were signiﬁcantly elevated compared4 Mediators of Inﬂammation
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Figure 1:KineticsofcfDNA/NETsaftermajortrauma.(a)cf-DNA/NETslevelsinpatients(n = 39)weresigniﬁcantlyenhancedaftertrauma
(P<0.01), versus control group (healthy volunteers). ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.0001, (b) cfDNA/NETs levels in patients who
developed sepsis during the ﬁrst 10 days after trauma (n = 14) were signiﬁcantly elevated when compared to the values determined in
patients with uneventful recovery (n = 25). The horizontal line across the boxplots represents the median, and the lower and upper ends
of the boxplots are the 25th and 75th percentiles, respectively. Whiskers indicate the minimum and maximum values, respectively versus no
sepsis group at the same time. #P<0.05, ##P<0.01 and ###P<0.0001.
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Figure 2: Kinetics of DNase after major trauma. (a) DNase values in patients (n = 39) were signiﬁcantly elevated early after trauma (∗P<
0.05 versus control group). (b) DNase levels in patients who developed sepsis during the ﬁrst 10 days after trauma (n = 14) did not show
any diﬀerences compared to the values determined in patients with uneventful recovery (n = 25) or control group (healthy volunteers). The
horizontal line across the boxplots represents the median, and the lower and upper ends of the boxplots are the 25th and 75th percentiles,
respectively. Whiskers indicate the minimum and maximum values, respectively.
topatientswithoutdevelopmentofsepsisaftermajortrauma
(P<0.05) and healthy volunteers (P<0.0001).
cf-DNA/NETs values strongly correlate to DNase values
(r = 0.2523, P<0.0001) after trauma. Furthermore, cf-
DNA/NETs concentrations determined in patients without
sepsis development after severe trauma strongly correlated
with DNase (r = 0.207, P<0.01). However, values did
not correlate in patients who subsequently developed sepsis
(r = 0.4771; P>0.05).
3.3. Degradation of NETs by DNase Treatment. In order to
prove the ability of DNase to degrade the scaﬀold of NETs inMediators of Inﬂammation 5
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Figure 3: Values of cfDNA/NETs and DNase in the early septic phase. Highest values of cf-DNA/NETs and DNase in the range between the
day before (−1), the day of (0), and the day after (+1) diagnosis of sepsis after major trauma. (a) cf-DNA/NETs values of patients with sepsis
weresigniﬁcantlyenhancedcomparedtopatientswithuneventfulrecovery(P<0.05)orhealthyvolunteers(P<0.0001).(b)Likewisevalues
of DNase of patients who developed sepsis after major trauma were signiﬁcantly enhanced compared to patients with uneventful recovery
(P<0.05) or healthy volunteers (P<0.05). The horizontal line across the boxplots represents the median, and the lower and upper ends of
the boxplots are the 25th and 75th percentiles, respectively. Whiskers indicate the minimum and maximum values, respectively. ∗P<0.05
and ∗∗∗P<0.0001.
vitro, supernatants of stimulated neutrophils were incubated
with DNase, and NETs were quantiﬁed by cf-DNA/NETs
assay. As depicted in Figure 4(a), NETs were disintegrated
in a concentration-dependent manner. Furthermore, qual-
itative evidence of DNase-mediated NET degradation has
been shown by immunoﬂuorescence (Figure 4(b)). Viable
unstimulated neutrophils from healthy volunteers and neu-
trophilsstimulatedwithPMAwereﬁxedandstainedforNET
components (blue = DNA, green = MPO). The image of
unstimulated neutrophils shows the nuclear localization of
DNA and the granular pattern of MPO (top right). After
stimulation, morphological changes during NET formation
could be determined with loss of nuclear lobules and
granular integrity of MPO (left bottom). Exposure of ﬁxed
NETs with rhDNase resulted in the disintegration of NETs
with loss of DNA structures (right bottom).
4. Discussion
Formation of NETs has been discussed as an eﬀective
mechanism of the innate immune system and as relevant
in infections, sepsis, and autoimmune diseases. NETs have
been shown to trap various types of pathogens [21, 24–
26]. Although NETs have been demonstrated to eﬀectively
enhance bacterial trapping, this antibacterial mechanism
occurs at the expense of injury to endothelium, tissue, and
organs [21, 27].
We could conﬁrm previously published results that cf-
DNA/NETs are enhanced in the serum of trauma patients,
especially those who later developed sepsis [28]. In this study
we could show that particularly cfDNA/NETs values were
enhanced in the very early phase of sepsis or even before
clinical manifestation. This suggests a certain regulatory
importanceofthisﬁnding.Furthermore,inthisphaseDNase
values in septic patients were also signiﬁcantly increased
compared to patients without sepsis and healthy volunteers.
Moreover, NETs released by stimulated neutrophils in vitro
were eﬃciently degradated by recombinant DNase in a
concentration-dependent manner. All the data obtained in
this study provide indication for an important pathophysio-
logical role of cf-DNA/NETs and their relationship to DNase
in the early phase of sepsis after trauma. The release of
DNase may on one hand inhibit the antibacterial eﬀects of
NETs on the other hand DNase could protect the tissue from
autodestruction caused by inadequate NETs release in septic
patients. Furthermore DNase itself may have a regulatory
function in NETs formation of neutrophils.
As their structural backbone is composed of chromatin,
NETs are destroyed by DNase. The endonuclease DNase is
the major nuclease normally produced by the pancreas and
salivary glands and is a physiological constituent of human
plasma at concentrations of approximately 3ng/mL [29].
Brinkmann et al. have already shown in vitro that brief
treatment of activated neutrophils with DNase abolishes
microbial killing by NETs [9]. In our study this DNase-
related dissociation of NETs in vitro has been conﬁrmed
byimmunoﬂuorescence.FurthermoreDNasedegradesNETs
in a concentration-dependent manner. As after trauma
DNase levels of all patients correlate to DNase values and
both were signiﬁcantly elevated in the early phase of sepsis
after major trauma, an immunological-based interaction is
possible. Given that NETs play a role in the pathogenesis
of diverse immune disorders, the formation and activity
of endogen-released DNases are prerequisites for natural
counter regulation. It ought to be taken into account
that adequate DNase release may inhibit the antibacterial
eﬀects of NETs or protect the tissue from autodestruction
in inadequate NETs release in septic patients. Physiologic
amountsofNETsarelikelytobeimportantinanti-infectious
innate immune responses. In contrast, aberrant amounts of6 Mediators of Inﬂammation
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Figure 4:DegradationofNETsbyDNaseinvitro.(a)DegradationofNETsinaconcentration-dependentmanner.Neutrophilswereisolated
from healthy volunteers (n = 5) and stimulated 3h with 50nM PMA. Then, the supernatants were incubated with 0, 0.02, 0.2, 2.0, and
20.0µg/mL rhDNase for 30 minutes and values of cfDNA/NETs were determined (n.d.: not detected). Data are presented as mean ± SEM.
(b) Immunoﬂuorescence staining of NETs. Neutrophils were stimulated with 30nM PMA for 3h and stained for DNA (blue) and MPO
(green). Cells were further incubated with 20µg/mL rhDNase.
NETs, not suﬃciently degraded by DNAses within the blood,
may occlude capillaries, impair microcirculation, enzymat-
ically damage tissues, and strongly promote inﬂammation.
Patients who have low amounts of DNases in their blood are
not able to adequately control NET formation and thus may
have a higher risk to develop severe sequelae than patients
with normal amounts of DNases.
Beside physiological production of DNases from pan-
creas and salivary gland cells, some bacteria protect them-
selves from trapping by degrading the NETs via endogenous
DNase [22]. DNases are expressed by many Gram-positive
bacterial pathogens [30], but their role in virulence has been
unclear until the discovery of NETs. Beiter et al. showed
that the surface endonuclease A (EndA) of Streptococcus
pneumoniae enabled the bacteria to escape the immune
system by degrading the DNA scaﬀolds of NETs [18]. Upon
degradation by extracellular DNases excessively accumulated
NETs within tissues or capillaries release NET-associated
eﬀector molecules enzymes such as neutrophil-derived elas-
tase which may entail severe tissue damage. However, the
eﬀects of these proteins when released from NETs after
degradation by natural or therapeutic DNase are unclear.
The assay used to label neutrophil-derived NETs by
targeting the NET containing cf-DNA directly within serum
has been recently developed. It has been shown to be speciﬁc
forneutrophilssincestimulationofotherbloodcellsorother
cells did not result in production of NETs or in increased
ﬂuorescencesignals[22,31].TheassumptionthatthecfDNA
is a component of ﬂoating NETs has been supported by
previous studies, in which MPO, as a granule component
of NETs, strongly correlates to cfDNA/NETs values [22, 32].
However, as rightly remarked by the reviewer the deﬁnite
proof in vivo that cfDNA largely derives from hyperactivated
neutrophils in patients after multiple trauma has to be done.
5. Conclusions
Values of cf-DNA/NETs and DNase are signiﬁcantly in-
creased in the early phase of sepsis after major trauma.
DNasedegradesNETsinaconcentration-dependentmannerMediators of Inﬂammation 7
and may have a regulatory eﬀect on NET formation in
neutrophils. This may inhibit the antibacterial eﬀects of
NETs or protect the tissue from autodestruction in inad-
equate NETs release in septic patients. Furthermore, ther-
apeutic strategies that limit NETs activity, for example,
by DNase or DNase inhibitors treatment might prevent
neutrophil-derived pathological eﬀects possibly resulting in
posttraumatic organ failure.
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